Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 12-16

  Law, Candy W Y ^a   Soczynska, Joanna K ^a,b   Woldeyohannes, Hanna O ^a   Miranda, Andrew ^a   Brooks III, John O ^c   McIntyre, Roger S ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bipolar disorder; Cognition; Neuropsychology; Nicotine

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE FUNCTIONING QUESTIONNAIRE; CONTROLLED STUDY; FEMALE; HUMAN; INTELLIGENCE; MALE; MEMORY CONSOLIDATION; MULTIPLE REGRESSION; NATIONAL ADULT READING TEST; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR DEVELOPMENT; QUESTIONNAIRE; READING; SAMPLE SIZE; SELF REPORT; STUDENT T TEST; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGED; ATTENTION; BIPOLAR DISORDER; COGNITION; FEMALE; HUMANS; INTELLIGENCE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; READING; SMOKING; VERBAL BEHAVIOR; VERBAL LEARNING; YOUNG ADULT;

EID: 58549100310     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.10.002     Document Type: Article

References (37)

1. Banos J.H., Dickson A.L., and Greer T. A computer-assisted administration of the Continuous Visual Memory Test. Clin Neuropsychol 15 (2001) 551-555
2. Barr R.S., Culhane M.A., Jubelt L.E., Mufti R.S., Dyer M.A., Weiss A.P., et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33 (2008) 480-490
3. Bearden C.E., Hoffman K.M., and Cannon T.D. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 3 (2001) 106-150
4. Bright P., Jaldow E., and Kopelman M.D. The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc 8 (2002) 847-854
5. Brucki S.M., and Rocha M.S. Category fluency test: effects of age, gender and education on total scores, clustering and switching in Brazilian Portuguese-speaking subjects. Braz J Med Biol Res 37 (2004) 1771-1777
6. Chouinard S., Sepehry A.A., and Stip E. Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I. Clin Neuropharmacol 30 (2007) 169-182
7. Corvin A., O'Mahony E., O'Regan M., Comerford C., O'Connell R., Craddock N., et al. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Psychiatry 179 (2001) 35-38
8. Delis D.C., Freeland J., Kramer J.H., and Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 56 (1988) 123-130
9. Drane D.L., Yuspeh R.L., Huthwaite J.S., and Klingler L.K. Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry Neuropsychol Behav Neurol 15 (2002) 39-43
10. Fadardi J.S., and Cox W.M. Alcohol attentional bias: drinking salience or cognitive impairment?. Psychopharmacology (Berl) 185 (2006) 169-178
11. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., and Russell M.A. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl) 127 (1996) 31-38
12. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., and Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61 (2004) 1107-1115
13. Gualtieri C.T., and Johnson L.G. Age-related cognitive decline in patients with mood disorders. Prog. Neuropsychopharmacol. Biol Psychiatry 32 (2008) 962-967
14. Hughes J.R., Hatsukami D.K., Mitchell J.E., and Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143 (1986) 993-997
15. Itkin O., Nemets B., and Einat H. Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J Clin Psychiatry 62 (2001) 269-272
16. Iversen L.L. Smoking... harmful to the brain. Nature 382 (1996) 206-207
17. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., and Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55 (2004) 850-858
18. Jones I.W., Westmacott A., Chan E., Jones R.W., Dineley K., O'Neill M.J., et al. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. J Mol Neurosci 30 (2006) 83-84
19. Keizer A.M., Hijman R., van D.D., Kalkman C.J., and Kahn R.S. Cognitive self-assessment one year after on-pump and off-pump coronary artery bypass grafting. Ann Thorac Surg 75 (2003) 835-838
20. Knott V., Bosman M., Mahoney C., Ilivitsky V., and Quirt K. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials. Pharmacol Biochem Behav 63 (1999) 253-261
21. Kumari V., Gray J.A., ffytche D.H., Mitterschiffthaler M.T., Das M., Zachariah E., et al. Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 19 (2003) 1002-1013
22. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., and Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 284 (2000) 2606-2610
23. Lawrence N.S., Ross T.J., and Stein E.A. Cognitive mechanisms of nicotine on visual attention. Neuron 36 (2002) 539-548
24. Levin E.D., and Rezvani A.H. Nicotinic treatment for cognitive dysfunction. Curr. Drug Targets. CNS. Neurol. Disord. vol. 1 (2002) 423-431
25. Levin E.D., and Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138 (1998) 217-230
26. Lohr J.B., and Flynn K. Smoking and schizophrenia. Schizophr Res 8 (1992) 93-102
27. Macqueen G., and Young T. Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disord 5 (2003) 53-61 Suppl 2
28. McIntyre R., Kennedy S., Bagby R.M., and Bakish D. Assessing full remission. J Psychiatry Neurosci 27 (2002) 235-239
29. McIntyre R.S., Konarski J.Z., Mancini D.A., Fulton K.A., Parikh S.V., Grigoriadis S., et al. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 173 (2005) 1327-1334
30. McIntyre R.S., Konarski J.Z., Soczynska J.K., Wilkins K., Panjwani G., Bouffard B., et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv 57 (2006) 1140-1144
31. Oquendo M.A., Galfalvy H., Russo S., Ellis S.P., Grunebaum M.F., Burke A., et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 161 (2004) 1433-1441
32. Ostacher M.J., Nierenberg A.A., Perlis R.H., Eidelman P., Borrelli D.J., Tran T.B., et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry 67 (2006) 1907-1911
33. Potter A.S., and Newhouse P.A. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav 88 (2008) 407-417
34. Robinson L.J., Thompson J.M., Gallagher P., Goswami U., Young A.H., Ferrier I.N., et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93 (2006) 105-115
35. Sacco K.A., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62 (2005) 649-659
36. Stip E., Chouinard S., and Boulay L.J. On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog. Neuropsychopharmacol. Biol Psychiatry 29 (2005) 219-232
37. Warburton D.M. Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16 (1992) 181-191